Growth Metrics

Pro Dex (PDEX) Current Deferred Revenue (2013 - 2026)

Pro Dex recorded quarterly Current Deferred Revenue of $144000.0 in Q1 2026, down 11.66% quarter-over-quarter from $163000.0 in Q4 2025.

Pro Dex's Current Deferred Revenue history runs 11 years deep, the most recent figure standing at $144000.0 for Q1 2026.

  • In Q1 2026, Current Deferred Revenue changed N/A year-over-year to $144000.0; the TTM figure through Mar 2026 stood at $144000.0 (changed N/A YoY), while the FY2025 annual figure was $202000.0, up 1342.86% from the prior year.
  • Current Deferred Revenue came in at $144000.0 for Q1 2026 at Pro Dex, down from $163000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $1.0 million in Q2 2022 to a low of $14000.0 in Q2 2024.
  • A 5-year average of $395272.7 and a median of $163000.0 in 2025 frame the typical range for Current Deferred Revenue.
  • Across the five-year window, Current Deferred Revenue slumped 93.64% in 2023 and soared 1342.86% in 2025, its largest moves.
  • Pro Dex's Current Deferred Revenue stood at $851000.0 in 2022, then tumbled by 93.3% to $57000.0 in 2023, then sank by 75.44% to $14000.0 in 2024, then soared by 1064.29% to $163000.0 in 2025, then decreased by 11.66% to $144000.0 in 2026.
  • According to Business Quant data, Current Deferred Revenue over the past three periods registered $144000.0, $163000.0, and $122000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Pro Dex 201.21 Mn 193.60 Mn 6.13 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 144,000.00
Dec 31, 2025 163,000.00
Sep 30, 2025 122,000.00
Jun 30, 2025 202,000.00
Jun 30, 2024 14,000.00
Mar 31, 2024 35,000.00
Mar 31, 2023 57,000.00
Dec 31, 2022 851,000.00
Sep 30, 2022 851,000.00
Jun 30, 2022 1.01 Mn
Mar 31, 2022 896,000.00
Dec 31, 2021 584,000.00
Sep 30, 2021 293,000.00
Jun 30, 2021 150,000.00
Jun 30, 2020 200,000.00
Sep 30, 2016 319,000.00
Jun 30, 2016 212,000.00
Mar 31, 2016 117,000.00
Jun 30, 2015 594,000.00
Mar 31, 2015 530,000.00
Jun 30, 2014 232,000.00
Mar 31, 2014 277,000.00
Dec 31, 2013 247,000.00
Sep 30, 2013 212,000.00
Jun 30, 2013 141,000.00